 | • レポートコード：D0804-14758 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、104ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、反毒素の世界市場を広く調査・分析し、今後の市場展望をまとめております。反毒素の種類別市場規模（多価アンチヴェノム、一価アンチヴェノム）、用途別市場規模（小売薬局、病院、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：CSL Behring、Vins Bioproducts、Pfizer、Merck & Co.、Flynn Pharma、BTG Plc、Serum Biotech、Rare Disease Therapeutics、Haffkine Bio-Pharmaceutical Corporation、Bharat Serums and Vaccines ・地域別グローバル市場分析 2015年-2020年 ・反毒素の北米市場（アメリカ、カナダ、メキシコ） ・反毒素のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・反毒素のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・反毒素の南米市場（ブラジル、アルゼンチン） ・反毒素の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：多価アンチヴェノム、一価アンチヴェノム ・用途別分析：小売薬局、病院、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019.
The Anti-Venom market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Anti-Venom market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Anti-Venom market has been segmented into:
Polyvalent Antivenom
Monovalent Antivenom
By Application, Anti-Venom has been segmented into:
Retail Pharmacies
Hospitals
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Anti-Venom market presented in the report. This section sheds light on the sales growth of different regional and country-level Anti-Venom markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Anti-Venom market.
The report offers in-depth assessment of the growth and other aspects of the Anti-Venom market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Anti-Venom Market Share Analysis
Anti-Venom competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Anti-Venom sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Anti-Venom sales, revenue and market share for each player covered in this report.
The major players covered in Anti-Venom are:
CSL Behring
Vins Bioproducts
Pfizer
Merck & Co.
Flynn Pharma
BTG Plc
Serum Biotech
Rare Disease Therapeutics
Haffkine Bio-Pharmaceutical Corporation
Bharat Serums and Vaccines
Table of Contents
1 Anti-Venom Market Overview
1.1 Product Overview and Scope of Anti-Venom
1.2 Classification of Anti-Venom by Type
1.2.1 Global Anti-Venom Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Anti-Venom Revenue Market Share by Type in 2019
1.2.3 Polyvalent Antivenom
1.2.4 Monovalent Antivenom
1.3 Global Anti-Venom Market by Application
1.3.1 Overview: Global Anti-Venom Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Retail Pharmacies
1.3.3 Hospitals
1.3.4 Others
1.4 Global Anti-Venom Market by Regions
1.4.1 Global Anti-Venom Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Anti-Venom (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Anti-Venom Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Anti-Venom Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anti-Venom Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Anti-Venom Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anti-Venom Status and Prospect (2015-2025)
2 Company Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL Behring SWOT Analysis
2.1.4 CSL Behring Product and Services
2.1.5 CSL Behring Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.2 Vins Bioproducts
2.2.1 Vins Bioproducts Details
2.2.2 Vins Bioproducts Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Vins Bioproducts SWOT Analysis
2.2.4 Vins Bioproducts Product and Services
2.2.5 Vins Bioproducts Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck & Co.
2.4.1 Merck & Co. Details
2.4.2 Merck & Co. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck & Co. SWOT Analysis
2.4.4 Merck & Co. Product and Services
2.4.5 Merck & Co. Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.5 Flynn Pharma
2.5.1 Flynn Pharma Details
2.5.2 Flynn Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Flynn Pharma SWOT Analysis
2.5.4 Flynn Pharma Product and Services
2.5.5 Flynn Pharma Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.6 BTG Plc
2.6.1 BTG Plc Details
2.6.2 BTG Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BTG Plc SWOT Analysis
2.6.4 BTG Plc Product and Services
2.6.5 BTG Plc Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.7 Serum Biotech
2.7.1 Serum Biotech Details
2.7.2 Serum Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Serum Biotech SWOT Analysis
2.7.4 Serum Biotech Product and Services
2.7.5 Serum Biotech Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.8 Rare Disease Therapeutics
2.8.1 Rare Disease Therapeutics Details
2.8.2 Rare Disease Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Rare Disease Therapeutics SWOT Analysis
2.8.4 Rare Disease Therapeutics Product and Services
2.8.5 Rare Disease Therapeutics Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.9 Haffkine Bio-Pharmaceutical Corporation
2.9.1 Haffkine Bio-Pharmaceutical Corporation Details
2.9.2 Haffkine Bio-Pharmaceutical Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Haffkine Bio-Pharmaceutical Corporation SWOT Analysis
2.9.4 Haffkine Bio-Pharmaceutical Corporation Product and Services
2.9.5 Haffkine Bio-Pharmaceutical Corporation Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bharat Serums and Vaccines
2.10.1 Bharat Serums and Vaccines Details
2.10.2 Bharat Serums and Vaccines Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bharat Serums and Vaccines SWOT Analysis
2.10.4 Bharat Serums and Vaccines Product and Services
2.10.5 Bharat Serums and Vaccines Anti-Venom Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Anti-Venom Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Anti-Venom Players Market Share
3.2.2 Top 10 Anti-Venom Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Anti-Venom Revenue and Market Share by Regions
4.2 North America Anti-Venom Revenue and Growth Rate (2015-2020)
4.3 Europe Anti-Venom Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Anti-Venom Revenue and Growth Rate (2015-2020)
4.5 South America Anti-Venom Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Anti-Venom Revenue and Growth Rate (2015-2020)
5 North America Anti-Venom Revenue by Countries
5.1 North America Anti-Venom Revenue by Countries (2015-2020)
5.2 USA Anti-Venom Revenue and Growth Rate (2015-2020)
5.3 Canada Anti-Venom Revenue and Growth Rate (2015-2020)
5.4 Mexico Anti-Venom Revenue and Growth Rate (2015-2020)
6 Europe Anti-Venom Revenue by Countries
6.1 Europe Anti-Venom Revenue by Countries (2015-2020)
6.2 Germany Anti-Venom Revenue and Growth Rate (2015-2020)
6.3 UK Anti-Venom Revenue and Growth Rate (2015-2020)
6.4 France Anti-Venom Revenue and Growth Rate (2015-2020)
6.5 Russia Anti-Venom Revenue and Growth Rate (2015-2020)
6.6 Italy Anti-Venom Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Anti-Venom Revenue by Countries
7.1 Asia-Pacific Anti-Venom Revenue by Countries (2015-2020)
7.2 China Anti-Venom Revenue and Growth Rate (2015-2020)
7.3 Japan Anti-Venom Revenue and Growth Rate (2015-2020)
7.4 Korea Anti-Venom Revenue and Growth Rate (2015-2020)
7.5 India Anti-Venom Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Anti-Venom Revenue and Growth Rate (2015-2020)
8 South America Anti-Venom Revenue by Countries
8.1 South America Anti-Venom Revenue by Countries (2015-2020)
8.2 Brazil Anti-Venom Revenue and Growth Rate (2015-2020)
8.3 Argentina Anti-Venom Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Anti-Venom by Countries
9.1 Middle East & Africa Anti-Venom Revenue by Countries (2015-2020)
9.2 Saudi Arabia Anti-Venom Revenue and Growth Rate (2015-2020)
9.3 UAE Anti-Venom Revenue and Growth Rate (2015-2020)
9.4 Egypt Anti-Venom Revenue and Growth Rate (2015-2020)
9.5 South Africa Anti-Venom Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Anti-Venom Revenue and Market Share by Type (2015-2020)
10.2 Global Anti-Venom Market Forecast by Type (2019-2024)
10.3 Polyvalent Antivenom Revenue Growth Rate (2015-2025)
10.4 Monovalent Antivenom Revenue Growth Rate (2015-2025)
11 Global Anti-Venom Market Segment by Application
11.1 Global Anti-Venom Revenue Market Share by Application (2015-2020)
11.2 Anti-Venom Market Forecast by Application (2019-2024)
11.3 Retail Pharmacies Revenue Growth (2015-2020)
11.4 Hospitals Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Anti-Venom Market Size Forecast (2021-2025)
12.1 Global Anti-Venom Market Size Forecast (2021-2025)
12.2 Global Anti-Venom Market Forecast by Regions (2021-2025)
12.3 North America Anti-Venom Revenue Market Forecast (2021-2025)
12.4 Europe Anti-Venom Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Anti-Venom Revenue Market Forecast (2021-2025)
12.6 South America Anti-Venom Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Anti-Venom Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Anti-Venom Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Anti-Venom by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Anti-Venom Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Anti-Venom Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. CSL Behring Corporate Information, Location and Competitors
Table 6. CSL Behring Anti-Venom Major Business
Table 7. CSL Behring Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 8. CSL Behring SWOT Analysis
Table 9. CSL Behring Anti-Venom Product and Solutions
Table 10. CSL Behring Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Vins Bioproducts Corporate Information, Location and Competitors
Table 12. Vins Bioproducts Anti-Venom Major Business
Table 13. Vins Bioproducts Anti-Venom Total Revenue (USD Million) (2018-2019)
Table 14. Vins Bioproducts SWOT Analysis
Table 15. Vins Bioproducts Anti-Venom Product and Solutions
Table 16. Vins Bioproducts Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Pfizer Corporate Information, Location and Competitors
Table 18. Pfizer Anti-Venom Major Business
Table 19. Pfizer Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 20. Pfizer SWOT Analysis
Table 21. Pfizer Anti-Venom Product and Solutions
Table 22. Pfizer Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Merck & Co. Corporate Information, Location and Competitors
Table 24. Merck & Co. Anti-Venom Major Business
Table 25. Merck & Co. Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 26. Merck & Co. SWOT Analysis
Table 27. Merck & Co. Anti-Venom Product and Solutions
Table 28. Merck & Co. Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Flynn Pharma Corporate Information, Location and Competitors
Table 30. Flynn Pharma Anti-Venom Major Business
Table 31. Flynn Pharma Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 32. Flynn Pharma SWOT Analysis
Table 33. Flynn Pharma Anti-Venom Product and Solutions
Table 34. Flynn Pharma Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BTG Plc Corporate Information, Location and Competitors
Table 36. BTG Plc Anti-Venom Major Business
Table 37. BTG Plc Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 38. BTG Plc SWOT Analysis
Table 39. BTG Plc Anti-Venom Product and Solutions
Table 40. BTG Plc Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Serum Biotech Corporate Information, Location and Competitors
Table 42. Serum Biotech Anti-Venom Major Business
Table 43. Serum Biotech Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 44. Serum Biotech SWOT Analysis
Table 45. Serum Biotech Anti-Venom Product and Solutions
Table 46. Serum Biotech Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Rare Disease Therapeutics Corporate Information, Location and Competitors
Table 48. Rare Disease Therapeutics Anti-Venom Major Business
Table 49. Rare Disease Therapeutics Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 50. Rare Disease Therapeutics SWOT Analysis
Table 51. Rare Disease Therapeutics Anti-Venom Product and Solutions
Table 52. Rare Disease Therapeutics Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Haffkine Bio-Pharmaceutical Corporation Corporate Information, Location and Competitors
Table 54. Haffkine Bio-Pharmaceutical Corporation Anti-Venom Major Business
Table 55. Haffkine Bio-Pharmaceutical Corporation Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 56. Haffkine Bio-Pharmaceutical Corporation SWOT Analysis
Table 57. Haffkine Bio-Pharmaceutical Corporation Anti-Venom Product and Solutions
Table 58. Haffkine Bio-Pharmaceutical Corporation Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Bharat Serums and Vaccines Corporate Information, Location and Competitors
Table 60. Bharat Serums and Vaccines Anti-Venom Major Business
Table 61. Bharat Serums and Vaccines Anti-Venom Total Revenue (USD Million) (2017-2018)
Table 62. Bharat Serums and Vaccines SWOT Analysis
Table 63. Bharat Serums and Vaccines Anti-Venom Product and Solutions
Table 64. Bharat Serums and Vaccines Anti-Venom Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Anti-Venom Revenue (Million USD) by Players (2015-2020)
Table 66. Global Anti-Venom Revenue Share by Players (2015-2020)
Table 67. Global Anti-Venom Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Anti-Venom Revenue Market Share by Regions (2015-2020)
Table 69. North America Anti-Venom Revenue by Countries (2015-2020)
Table 70. North America Anti-Venom Revenue Market Share by Countries (2015-2020)
Table 71. Europe Anti-Venom Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Anti-Venom Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Anti-Venom Revenue by Countries (2015-2020)
Table 74. South America Anti-Venom Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Anti-Venom Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Anti-Venom Revenue Market Share by Countries (2015-2020)
Table 77. Global Anti-Venom Revenue (Million USD) by Type (2015-2020)
Table 78. Global Anti-Venom Revenue Share by Type (2015-2020)
Table 79. Global Anti-Venom Revenue Forecast by Type (2021-2025)
Table 80. Global Anti-Venom Revenue by Application (2015-2020)
Table 81. Global Anti-Venom Revenue Share by Application (2015-2020)
Table 82. Global Anti-Venom Revenue Forecast by Application (2021-2025)
Table 83. Global Anti-Venom Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Anti-Venom Picture
Figure 2. Global Anti-Venom Revenue Market Share by Type in 2019
Figure 3. Polyvalent Antivenom Picture
Figure 4. Monovalent Antivenom Picture
Figure 5. Anti-Venom Revenue Market Share by Application in 2019
Figure 6. Retail Pharmacies Picture
Figure 7. Hospitals Picture
Figure 8. Others Picture
Figure 9. Global Anti-Venom Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Anti-Venom Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Anti-Venom Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Anti-Venom Revenue Market Share in 2019
Figure 18. Global Top 10 Players Anti-Venom Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Anti-Venom Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Anti-Venom Revenue Market Share by Regions (2015-2020)
Figure 22. Global Anti-Venom Revenue Market Share by Regions in 2018
Figure 23. North America Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 24. Europe Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 26. South America Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 28. North America Anti-Venom Revenue Market Share by Countries (2015-2020)
Figure 29. North America Anti-Venom Revenue Market Share by Countries in 2019
Figure 30. USA Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 31. Canada Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 33. Europe Anti-Venom Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Anti-Venom Revenue Market Share by Countries in 2019
Figure 35. Germany Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 36. UK Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 37. France Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 38. Russia Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 39. Italy Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Anti-Venom Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Anti-Venom Revenue Market Share by Countries in 2019
Figure 42. China Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 43. Japan Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 44. Korea Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 45. India Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 47. South America Anti-Venom Revenue Market Share by Countries (2015-2020)
Figure 48. South America Anti-Venom Revenue Market Share by Countries in 2019
Figure 49. Brazil Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Anti-Venom Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Anti-Venom Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 54. UAE Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Anti-Venom Revenue and Growth Rate (2015-2020)
Figure 57. Global Anti-Venom Revenue Share by Type (2015-2020)
Figure 58. Global Anti-Venom Revenue Share by Type in 2019
Figure 59. Global Anti-Venom Market Share Forecast by Type (2021-2025)
Figure 60. Global Polyvalent Antivenom Revenue Growth Rate (2015-2020)
Figure 61. Global Monovalent Antivenom Revenue Growth Rate (2015-2020)
Figure 62. Global Anti-Venom Revenue Share by Application (2015-2020)
Figure 63. Global Anti-Venom Revenue Share by Application in 2019
Figure 64. Global Anti-Venom Market Share Forecast by Application (2021-2025)
Figure 65. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Anti-Venom Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Anti-Venom Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Anti-Venom Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Anti-Venom Revenue Market Forecast (2021-2025)
Figure 72. Europe Anti-Venom Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Anti-Venom Revenue Market Forecast (2021-2025)
Figure 74. South America Anti-Venom Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Anti-Venom Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
反毒素の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-Venom market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.5% in the forecast period of 2020 to 2025 and will expected to reach USD 991.8 million by 2025, from USD 898.9 million in 2019. The Anti-Venom market report pr…- 抗血管内皮増殖因子（抗VEGF）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Anti-vascular Endothelial Growth Factor (Anti-VEGF) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global marke…
- 防滑ねじの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-slip Screw market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-slip Screw market report…
- アンチエイジング薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti-Ageing Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 7.2% in the forecast period of 2020 to 2025 and will expected to reach USD 106360 million by 2025, from USD 80490 million in 2019. The Anti-Ageing Drugs m…
- アンチエイジングの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Anti-aging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.8% in the forecast period of 2020 to 2025 and will expected to reach USD 1432780 million by 2025, from USD 1231970 million in 2019. The Anti-aging market repor…